Shell Company Status. To the Company's knowledge, the Company is not, and has never been, an issuer identified in Rule 144(i)(1) of the Securities Act. The Company is, and has been for a period of at least 90 days, subject to the reporting requirements of Section 13 or Section 15(d) of the Exchange Act. The Company has filed its current "Form 10 information" with the SEC pursuant to and in accordance with applicable requirements reflecting its status as an entity that is no longer an issuer described in Rule 144(i)(1) and at least one (1) year has elapsed from the date that the Company filed "Form 10 information" with the SEC.
Appears in 8 contracts
Sources: Subscription Agreement (Paulson Capital (Delaware) Corp.), Subscription Agreement (Paulson Capital (Delaware) Corp.), Subscription Agreement (Paulson Capital (Delaware) Corp.)
Shell Company Status. To the Company's knowledge, the The Company is not, and has never beennot been since July 14, 2013, an issuer identified in Rule 144(i)(1) of the Securities 1933 Act. The As of July 14, 2013, the Company is, and has been for a period of at least 90 days, subject to the reporting requirements of Section 13 or Section 15(d) of the Exchange Act. The Company has filed its current "“Form 10 information" ” (as defined in Rule 144 (i)(3)) with the SEC pursuant to and in accordance with applicable requirements reflecting its status as an entity that is was no longer an issuer described in Rule 144(i)(1) and at least one (1) year has elapsed from the date that the Company filed "Form 10 information" with the SEC144(i)(1)(i).
Appears in 8 contracts
Sources: Securities Purchase Agreement (Ener-Core, Inc.), Securities Purchase Agreement (Ener-Core, Inc.), Securities Purchase Agreement (Ener-Core, Inc.)
Shell Company Status. To the Company's knowledge, the The Company is notnot currently, and since October 27, 2011, has never not been, an issuer identified in Rule 144(i)(1) of under the Securities Act and has filed with the SEC current “Form 10 information” (as defined in Rule 144(i)(3) under the Securities Act. The Company is, and has been for a period of ) at least 90 days, subject 12 calendar months prior to the reporting requirements date of Section 13 or Section 15(d) of the Exchange Act. The Company has filed its current "Form 10 information" with the SEC pursuant to and in accordance with applicable requirements this Agreement reflecting its status as an entity that is no longer an issuer described identified in Rule 144(i)(1) and at least one (1) year has elapsed from under the date that the Company filed "Form 10 information" with the SECSecurities Act.
Appears in 8 contracts
Sources: Purchase Agreement (Tonix Pharmaceuticals Holding Corp.), Purchase Agreement (Tonix Pharmaceuticals Holding Corp.), Purchase Agreement (Tonix Pharmaceuticals Holding Corp.)
Shell Company Status. To the Company's knowledge, the The Company is not, and has never been, not currently an issuer identified in Rule 144(i)(1) of under the Securities Act. The Company is, Act and has been for a period of at least 90 days, subject to the reporting requirements of Section 13 or Section 15(d) of the Exchange Act. The Company has filed its current "all “Form 10 information" ” required by Rule 144(i)(1) under the Securities Act with the SEC pursuant to and in accordance with applicable requirements reflecting its status as an entity that is no longer an issuer described in Rule 144(i)(1) and at least one (1) year has elapsed from the date that the Company filed "Form 10 information" with the SECof December 31, 2022.
Appears in 7 contracts
Sources: Strata Purchase Agreement (Specificity, Inc.), Strata Purchase Agreement (Clean Vision Corp), Strata Purchase Agreement (Clean Vision Corp)
Shell Company Status. To the Company's knowledge, the The Company is not, and has never beennot been for a period of at least one year from the date hereof, an issuer identified in Rule 144(i)(1) of the Securities Act. The Company is, and has been for a period of at least 90 days, subject to the reporting requirements of Section 13 or Section 15(d) of the Exchange 1933 Act. The Company has filed its current "“Form 10 information" ” (as defined in Rule 144(i)(3)) with the SEC pursuant to and in accordance with applicable requirements reflecting its status as an entity that is was no longer an issuer described in Rule 144(i)(1144(i)(1)(i) and at least more than one (1) year has elapsed ago from the date that the Company filed "Form 10 information" with the SEChereof.
Appears in 6 contracts
Sources: Securities Purchase Agreement (Taronis Technologies, Inc.), Securities Purchase Agreement (Taronis Technologies, Inc.), Securities Purchase Agreement (Taronis Technologies, Inc.)
Shell Company Status. To the Company's knowledge, the The Company is not, and has never been, an issuer identified in Rule 144(i)(1) of under the Securities Act and has filed with the SEC current “Form 10 information” (as defined in Rule 144(i)(3) under the Securities Act. The Company is, and has been for a period of ) at least 90 days, subject 12 calendar months prior to the reporting requirements date of Section 13 or Section 15(d) of the Exchange Act. The Company has filed its current "Form 10 information" with the SEC pursuant to and in accordance with applicable requirements this Agreement reflecting its status as an entity that is no longer an issuer described identified in Rule 144(i)(1) and at least one (1) year has elapsed from under the date that the Company filed "Form 10 information" with the SECSecurities Act.
Appears in 6 contracts
Sources: Purchase Agreement (Chicken Soup for the Soul Entertainment, Inc.), Purchase Agreement (Venus Concept Inc.), Purchase Agreement (VYNE Therapeutics Inc.)
Shell Company Status. To the Company's knowledge, the The Company is not, and has never beennot been since July 14, 2013, an issuer identified in Rule 144(i)(1) of the Securities 1933 Act. The As of July 14, 2013, the Company is, and has been for a period of at least 90 days, subject to the reporting requirements of Section 13 or Section 15(d) of the Exchange Act. The Company has filed its current "Form 10 information" (as defined in Rule 144 (i)(3)) with the SEC pursuant to and in accordance with applicable requirements reflecting its status as an entity that is was no longer an issuer described in Rule 144(i)(1) and at least one (1) year has elapsed from the date that the Company filed "Form 10 information" with the SEC144(i)(1)(i).
Appears in 5 contracts
Sources: Securities Purchase Agreement (Ener-Core Inc.), Securities Purchase Agreement (Ener-Core Inc.), Securities Purchase Agreement (Ener-Core Inc.)
Shell Company Status. To the Company's knowledge, the The Company is not, and has never beennot been in the past twenty-four (24) months, an issuer identified in Rule 144(i)(1144(i)(1)(i) of the Securities Act. The Company is, and has been for a period of at least 90 days, subject to filed with the reporting requirements of Section 13 or Section 15(d) of the Exchange Act. The Company has filed its SEC current "“Form 10 information" with ” (as defined in Rule 144(i)(3)) at least twelve (12) months prior to the SEC pursuant to and in accordance with applicable requirements date of this Agreement reflecting its status as an entity that is no longer an issuer described identified in Rule 144(i)(1) and at least one (1) year has elapsed from the date that the Company filed "Form 10 information" with the SEC144(i)(1)(i).
Appears in 5 contracts
Sources: Purchase Agreement (Humacyte, Inc.), Purchase Agreement (Enochian Biosciences Inc), Purchase Agreement (Nutex Health, Inc.)
Shell Company Status. To the Company's knowledge, the The Company is not, and has never beennot been in the past twenty-four (24) months, an issuer identified in Rule 144(i)(1144(i)(1)(i) of the Securities Act. The Company isand, and has been for a period of at least 90 daysif so, subject to the reporting requirements of Section 13 or Section 15(d) of the Exchange Act. The Company has filed its with the SEC current "“Form 10 information" with ” (as defined in Rule 144(i)(3)) at least twelve (12) months prior to the SEC pursuant to and in accordance with applicable requirements date of this Agreement reflecting its status as an entity that is no longer an issuer described identified in Rule 144(i)(1) and at least one (1) year has elapsed from the date that the Company filed "Form 10 information" with the SEC144(i)(1)(i).
Appears in 5 contracts
Sources: Purchase Agreement (FTC Solar, Inc.), Purchase Agreement (Dolphin Entertainment, Inc.), Purchase Agreement (Acurx Pharmaceuticals, Inc.)
Shell Company Status. To the Company's knowledge, the The Company is not, and has never beennot been for a period of at least one year from the date hereof, an issuer identified in Rule 144(i)(1) of the Securities Act. The Company is, and has been for a period of at least 90 days, subject to the reporting requirements of Section 13 or Section 15(d) of the Exchange Act. The Company has filed its current "“Form 10 information" ” (as defined in Rule 144(i)(3)) with the SEC pursuant to and in accordance with applicable requirements reflecting its status as an entity that is was no longer an issuer described in Rule 144(i)(1144(i)(1)(i) and at least more than one (1) year has elapsed ago from the date that hereof. The Company shall provide a legal opinion of counsel to the Company filed "Form 10 information" in a form reasonably acceptable to the Purchaser with the SECrespect to this representation.
Appears in 5 contracts
Sources: Securities Purchase Agreement (HCW Biologics Inc.), Securities Purchase Agreement (HCW Biologics Inc.), Securities Purchase Agreement (International Land Alliance Inc.)
Shell Company Status. To the Company's knowledge, the The Company is not, and has never beennot been since September 4, 2013, an issuer identified in Rule 144(i)(1) of the Securities 1933 Act. The As of September 4, 2013, the Company is, and has been for a period of at least 90 days, subject to the reporting requirements of Section 13 or Section 15(d) of the Exchange Act. The Company has filed its current "“Form 10 information" ” (as defined in Rule 144 (i)(3)) with the SEC pursuant to and in accordance with applicable requirements reflecting its status as an entity that is was no longer an issuer described in Rule 144(i)(1) and at least one (1) year has elapsed from the date that the Company filed "Form 10 information" with the SEC144(i)(1)(i).
Appears in 4 contracts
Sources: Securities Purchase Agreement (Enerpulse Technologies, Inc.), Securities Purchase Agreement (Enerpulse Technologies, Inc.), Securities Purchase Agreement (Enerpulse Technologies, Inc.)
Shell Company Status. To the Company's knowledge, the The Company is not, and has never been, an issuer identified in Rule 144(i)(1) of under the Securities Act. The Company is, Act and has been for a period of at least 90 days, subject to filed with the reporting requirements of Section 13 or Section 15(d) of the Exchange Act. The Company has filed its SEC current "Form 10 information" with (as defined in Rule 144(i)(3) under the SEC pursuant Securities Act) at least 12 calendar months prior to and in accordance with applicable requirements the date of this Agreement reflecting its status as an entity that is no longer an issuer described identified in Rule 144(i)(1) and at least one (1) year has elapsed from under the date that the Company filed "Form 10 information" with the SECSecurities Act.
Appears in 3 contracts
Sources: Purchase Agreement (Portage Biotech Inc.), Purchase Agreement (Biodesix Inc), Purchase Agreement (X4 Pharmaceuticals, Inc)
Shell Company Status. To the Company's knowledge, the The Company is not, and has never not been in the past twenty-four (24) months been, an issuer identified in Rule 144(i)(1) of under the Securities Act and has filed with the SEC current “Form 10 information” (as defined in Rule 144(i)(3) under the Securities Act. The Company is, and has been for a period of ) at least 90 days, subject twelve (12) months prior to the reporting requirements date of Section 13 or Section 15(d) of the Exchange Act. The Company has filed its current "Form 10 information" with the SEC pursuant to and in accordance with applicable requirements this Agreement reflecting its status as an entity that is no longer an issuer described identified in Rule 144(i)(1) and at least one (1) year has elapsed from under the date that the Company filed "Form 10 information" with the SECSecurities Act.
Appears in 3 contracts
Sources: Purchase Agreement (Lithium Corp), Purchase Agreement (Aileron Therapeutics Inc), Purchase Agreement (Enochian Biosciences Inc)
Shell Company Status. To the Company's knowledge, the The Company is notnot currently, and since January 31, 2013 has never not been, an issuer identified in Rule 144(i)(1) of under the Securities Act and has filed with the SEC current “Form 10 information” (as defined in Rule 144(i)(3) under the Securities Act. The Company is, and has been for a period of ) at least 90 days, subject 12 calendar months prior to the reporting requirements date of Section 13 or Section 15(d) of the Exchange Act. The Company has filed its current "Form 10 information" with the SEC pursuant to and in accordance with applicable requirements this Agreement reflecting its status as an entity that is no longer an issuer described identified in Rule 144(i)(1) and at least one (1) year has elapsed from under the date that the Company filed "Form 10 information" with the SECSecurities Act.
Appears in 3 contracts
Sources: Common Stock Purchase Agreement (XOMA Corp), Common Stock Purchase Agreement (Rezolute, Inc.), Purchase Agreement (Rezolute, Inc.)
Shell Company Status. To the Company's knowledge, the The Company is not, and since January 25, 2022 has never not been, an issuer identified in Rule 144(i)(1) ). As of January 31, 2022, the Securities Act. The Company is, and has been for a period of at least 90 days, subject to the reporting requirements of Section 13 or Section 15(d) of the Exchange Act. The Company has filed its current "“Form 10 information" Information” (as defined in Rule 144(i)(3)) with the SEC pursuant to and in accordance with applicable requirements reflecting its status as an entity that is was no longer an issuer described in Rule 144(i)(1) and at least one (1) year has elapsed from the date that the Company filed "Form 10 information" with the SEC144(i)(1)(i).
Appears in 2 contracts
Sources: Securities Purchase Agreement (Sky Harbour Group Corp), Securities Purchase Agreement (Sky Harbour Group Corp)
Shell Company Status. To the Company's knowledge, the The Company is notnot currently, and has never beennot been during the three-year period prior to the date hereof, an issuer identified in Rule 144(i)(1) of under the Securities Act. The Company is, and has been for a period of at least 90 days, subject to the reporting requirements of Section 13 or Section 15(d) of the Exchange Act. The Company has filed its current "“Form 10 information" ” (as defined in Rule 144(i)(3) under the Securities Act) with the SEC pursuant at least three years prior to and in accordance with applicable requirements the date hereof reflecting its status as an entity that is no longer an issuer described in Rule 144(i)(1) and at least one (1) year has elapsed from the date that the Company filed "Form 10 information" with the SECnot a shell company.
Appears in 2 contracts
Sources: Purchase Agreement (BioCardia, Inc.), Purchase Agreement (Anthera Pharmaceuticals Inc)
Shell Company Status. To the Company's knowledge, the The Company is not, and has never beennot been at any time since at least January 13, 2017, an issuer identified in Rule 144(i)(1) of under the Securities Act and has filed with the SEC current “Form 10 information” (as defined in Rule 144(i)(3) under the Securities Act. The Company is, and has been for a period of ) at least 90 days, subject 12 calendar months prior to the reporting requirements date of Section 13 or Section 15(d) of the Exchange Act. The Company has filed its current "Form 10 information" with the SEC pursuant to and in accordance with applicable requirements this Agreement reflecting its status as an entity that is no longer an issuer described identified in Rule 144(i)(1) and at least one (1) year has elapsed from under the date that the Company filed "Form 10 information" with the SECSecurities Act.
Appears in 2 contracts
Sources: Purchase Agreement (Beyond Air, Inc.), Purchase Agreement (AIT Therapeutics, Inc.)
Shell Company Status. To the Company's knowledge, the The Company is not, and has never been, not an issuer identified in Rule 144(i)(1) of under the Securities Act and has filed with the SEC on September 18, 2017 current “Form 10 information” (as defined in Rule 144(i)(3) under the Securities Act. The Company is, and has been for a period of at least 90 days, subject to the reporting requirements of Section 13 or Section 15(d) of the Exchange Act. The Company has filed its current "Form 10 information" with the SEC pursuant to and in accordance with applicable requirements reflecting its status as an entity that is no longer not an issuer described identified in Rule 144(i)(1144(i)(1)(i) and at least one (1) year has elapsed from under the date that the Company filed "Form 10 information" with the SECSecurities Act.
Appears in 2 contracts
Sources: Purchase Agreement (Enveric Biosciences, Inc.), Purchase Agreement (Enveric Biosciences, Inc.)
Shell Company Status. To the Company's knowledge, the The Company is not, and has never been, not currently an issuer identified in Rule 144(i)(1) of under the Securities Act. The Company is, Act and has been for a period of at least 90 days, subject to the reporting requirements of Section 13 or Section 15(d) of the Exchange Act. The Company has filed its current "all “Form 10 information" ” required by Rule 144(i)(1) under the Securities Act with the SEC pursuant to and in accordance with applicable requirements reflecting its status as an entity that is no longer an issuer described in Rule 144(i)(1) and at least one (1) year has elapsed from the date that the Company filed "Form 10 information" with the SECof December 31, 2024.
Appears in 2 contracts
Sources: Strata Purchase Agreement (Foxo Technologies Inc.), Strata Purchase Agreement (Freedom Holdings, Inc.)
Shell Company Status. To the Company's knowledge, the The Company is not, and has never beennot been since September 26, 2017, an issuer identified in Rule 144(i)(1) of the Securities Act. The Company is, and has been for a period of at least 90 days, subject to the reporting requirements of Section 13 or Section 15(d) of the Exchange Act. The Company has filed its current "“Form 10 information" ” (as defined in Rule 144 (i)(3)) with the SEC pursuant to and in accordance with applicable requirements reflecting its status as an entity that is was no longer an issuer described in Rule 144(i)(1144(i)(1)(i) and at least more than one (1) year has elapsed ago from the date that the Company filed "Form 10 information" with the SEChereof.
Appears in 2 contracts
Sources: Securities Purchase Agreement (Exicure, Inc.), Securities Purchase Agreement (Exicure, Inc.)
Shell Company Status. To the Company's knowledge, the The Company is not, and has never been, an issuer identified in Rule 144(i)(1) of under the Securities Act. The Company is, Act and has been for a period of at least 90 days, subject to filed with the reporting requirements of Section 13 or Section 15(d) of the Exchange Act. The Company has filed its SEC current "Form 10 information" with (as defined in Rule 144(i)(3) under the SEC pursuant Securities Act) at least 12 calendar months prior to and in accordance with applicable requirements the date of this Agreement reflecting its status as an entity that is no longer not an issuer described identified in Rule 144(i)(1) and at least one (1) year has elapsed from under the date that the Company filed "Form 10 information" with the SECSecurities Act.
Appears in 2 contracts
Sources: Purchase Agreement (Cognition Therapeutics Inc), Purchase Agreement (Zynerba Pharmaceuticals, Inc.)
Shell Company Status. To the Company's knowledge, the The Company is not, and has never beennot been in the past twenty-four (24) months, an issuer identified in Rule 144(i)(1) of the Securities Act. The Company is, and has been for a period of at least 90 days, subject to filed with the reporting requirements of Section 13 or Section 15(d) of the Exchange Act. The Company has filed its SEC current "“Form 10 information" with ” (as defined in Rule 144(i)(3)) at least twelve (12) months prior to the SEC pursuant to and in accordance with applicable requirements date of this Agreement reflecting its status as an entity that is no longer an issuer described identified in Rule 144(i)(1) and at least one (1) year has elapsed from the date that the Company filed "Form 10 information" with the SEC).
Appears in 2 contracts
Sources: Purchase Agreement (Evaxion Biotech a/S), Purchase Agreement (Trevi Therapeutics, Inc.)
Shell Company Status. To the Company's knowledge, the Company is not, and has never been, not an issuer identified in Rule 144(i)(1) of the Securities Act. The Company is, and has been for a period of at least 90 days, subject to the reporting requirements of Section 13 or Section 15(d) of the Exchange Act. The Company has filed its current "Form 10 information" with the SEC pursuant to and in accordance with applicable requirements reflecting its status as an entity that is no longer an issuer described in Rule 144(i)(1) and at least one (1) year has elapsed from the date that the Company filed "Form 10 information" with the SEC.
Appears in 2 contracts
Sources: Subscription Agreement (Bitcoin Shop Inc.), Subscription Agreement (Bitcoin Shop Inc.)
Shell Company Status. To the Company's knowledge, the The Company is not, and has never been, not currently an issuer identified in Rule 144(i)(1) of under the Securities Act. The Company is, Act and has been for a period of at least 90 days, subject to the reporting requirements of Section 13 or Section 15(d) of the Exchange Act. The Company has filed its current "all “Form 10 information" ” required by Rule 144(i)(1) under the Securities Act with the SEC pursuant to and in accordance with applicable requirements reflecting its status as an entity that is no longer an issuer described in Rule 144(i)(1) and at least one (1) year has elapsed from the date that the Company filed "Form 10 information" with the SECof June 30, 2022.
Appears in 1 contract
Shell Company Status. To the Company's knowledge, the The Company is notnot currently, and since July 21, 2021, has never not been, an issuer identified in Rule 144(i)(1) of under the Securities Act and has filed with the SEC current “Form 10 information” (as defined in Rule 144(i)(3) under the Securities Act. The Company is, and has been for a period of ) at least 90 days, subject 12 calendar months prior to the reporting requirements date of Section 13 or Section 15(d) of the Exchange Act. The Company has filed its current "Form 10 information" with the SEC pursuant to and in accordance with applicable requirements this Agreement reflecting its status as an entity that is no longer an issuer described identified in Rule 144(i)(1) and at least one (1) year has elapsed from under the date that the Company filed "Form 10 information" with the SECSecurities Act.
Appears in 1 contract
Shell Company Status. To the Company's knowledge, the The Company is not, and has never been, not currently an issuer identified in Rule 144(i)(1) of under the Securities Act. The Company is, Act and has been for a period of at least 90 days, subject to the reporting requirements of Section 13 or Section 15(d) of the Exchange Act. The Company has filed its current "all “Form 10 information" ” required by Rule 144(i)(1) under the Securities Act with the SEC pursuant to and in accordance with applicable requirements reflecting its status as an entity that is no longer an issuer described in Rule 144(i)(1) and at least one (1) year has elapsed from the date that the Company filed "Form 10 information" with the SECof May 4, 2020.
Appears in 1 contract
Shell Company Status. To the Company's knowledge, the The Company is not, and has never beennot been since January 1, 2014, an issuer identified in Rule 144(i)(1) of the Securities Act. The As of January 1, 2014, the Company is, and has been for a period of at least 90 days, subject to the reporting requirements of Section 13 or Section 15(d) of the Exchange Act. The Company has filed its current "Form 10 information" (as defined in Rule 144 (i)(3)) with the SEC pursuant to and in accordance with applicable requirements reflecting its status as an entity that is was no longer an issuer described in Rule 144(i)(1) and at least one (1) year has elapsed from the date that the Company filed "Form 10 information" with the SEC144(i)(1)(i).
Appears in 1 contract
Sources: Securities Purchase Agreement (Root9B Technologies, Inc.)
Shell Company Status. To the Company's knowledge, the The Company is not, and has never been, not currently an issuer identified in Rule 144(i)(1) of under the Securities Act. The Company is, Act and has been for a period of at least 90 days, subject to the reporting requirements of Section 13 or Section 15(d) of the Exchange Act. The Company has filed its current "all “Form 10 information" ” required by Rule 144(i)(1) under the Securities Act with the SEC pursuant to and in accordance with applicable requirements reflecting its status as an entity that is no longer an issuer described in Rule 144(i)(1) and at least one (1) year has elapsed from the date that the Company filed "Form 10 information" with the SECof December 31, 2023.
Appears in 1 contract
Shell Company Status. To the Company's knowledge, the The Company is notnot currently, and since October 26, 2010 has never not been, an issuer identified in Rule 144(i)(1) of under the Securities Act and has filed with the SEC current “Form 10 information” (as defined in Rule 144(i)(3) under the Securities Act. The Company is, and has been for a period of ) at least 90 days, subject 12 calendar months prior to the reporting requirements date of Section 13 or Section 15(d) of the Exchange Act. The Company has filed its current "Form 10 information" with the SEC pursuant to and in accordance with applicable requirements this Agreement reflecting its status as an entity that is no longer an issuer described identified in Rule 144(i)(1) and at least one (1) year has elapsed from under the date that the Company filed "Form 10 information" with the SECSecurities Act.
Appears in 1 contract
Sources: Purchase Agreement (Invivo Therapeutics Holdings Corp.)
Shell Company Status. To the Company's knowledge, the The Company is not, and has never been, not currently an issuer identified in Rule 144(i)(1) of under the Securities Act. The Company is, Act and has been for a period of at least 90 days, subject to the reporting requirements of Section 13 or Section 15(d) of the Exchange Act. The Company has filed its current all "Form 10 information" required by Rule 144(i)(1) under the Securities Act with the SEC pursuant to and in accordance with applicable requirements reflecting its status as an entity that is no longer an issuer described in Rule 144(i)(1) and at least one (1) year has elapsed from the date that the Company filed "Form 10 information" with the SECof September 30, 2021.
Appears in 1 contract
Shell Company Status. To the Company's knowledge, the The Company is notnot currently, and since October 4, 2017, has never not been, an issuer identified in Rule 144(i)(1) of under the Securities Act and has filed with the SEC current “Form 10 information” (as defined in Rule 144(i)(3) under the Securities Act. The Company is, and has been for a period of ) at least 90 days, subject 12 calendar months prior to the reporting requirements date of Section 13 or Section 15(d) of the Exchange Act. The Company has filed its current "Form 10 information" with the SEC pursuant to and in accordance with applicable requirements this Agreement reflecting its status as an entity that is no longer an issuer described identified in Rule 144(i)(1) and at least one (1) year has elapsed from under the date that the Company filed "Form 10 information" with the SECSecurities Act.
Appears in 1 contract
Sources: Purchase Agreement (Processa Pharmaceuticals, Inc.)
Shell Company Status. To the Company's knowledge, the The Company is not, and has never been, not currently an issuer identified in Rule 144(i)(1) of under the Securities Act and has filed with the SEC current “Form 10 information” (as defined in Rule 144(i)(3) under the Securities Act. The Company is, and has been for a period of ) at least 90 days, subject 12 calendar months prior to the reporting requirements date of Section 13 or Section 15(d) of the Exchange Act. The Company has filed its current "Form 10 information" with the SEC pursuant to and in accordance with applicable requirements this Agreement reflecting its status as an entity that is no longer an issuer described identified in Rule 144(i)(1) and at least one (1) year has elapsed from under the date that the Company filed "Form 10 information" with the SECSecurities Act.
Appears in 1 contract
Shell Company Status. To the Company's knowledge, the The Company is notnot currently, and since January 5, 2021, has never not been, an issuer identified in Rule 144(i)(1) of under the Securities Act and has filed with the SEC current “Form 10 information” (as defined in Rule 144(i)(3) under the Securities Act. The Company is, and has been for a period of ) at least 90 days, subject 12 calendar months prior to the reporting requirements date of Section 13 or Section 15(d) of the Exchange Act. The Company has filed its current "Form 10 information" with the SEC pursuant to and in accordance with applicable requirements this Agreement reflecting its status as an entity that is no longer an issuer described identified in Rule 144(i)(1) and at least one (1) year has elapsed from under the date that the Company filed "Form 10 information" with the SECSecurities Act.
Appears in 1 contract
Sources: Purchase Agreement (Clene Inc.)
Shell Company Status. To the Company's ’s knowledge, the Company is not, and has never been, not an issuer identified in Rule 144(i)(1) of the Securities Act. The Company is, and has been for a period of at least 90 days, subject to the reporting requirements of Section 13 or Section 15(d) of the Exchange Act. The Company has filed its current "“Form 10 information" ” with the SEC pursuant to and in accordance with applicable requirements reflecting its status as an entity that is no longer an issuer described in Rule 144(i)(1) and at least one (1) year has elapsed from the date that the Company filed "“Form 10 information" ” with the SEC.
Appears in 1 contract
Shell Company Status. To the Company's knowledge, the The Company is not, and has never been, an issuer identified in Rule 144(i)(1) of under the Securities Act. The Company is, Act and has been for a period of at least 90 days, subject to filed with the reporting requirements of Section 13 or Section 15(d) of the Exchange Act. The Company has filed its SEC current "Form 10 information" with (as defined in Rule 144(i)(3) under the SEC pursuant Securities Act) at least 12 calendar months prior to and in accordance with applicable requirements the date of this Agreement reflecting its status as an entity that is no longer not an issuer described identified in Rule 144(i)(1144(i)(1)(i) and at least one (1) year has elapsed from under the date that the Company filed "Form 10 information" with the SECSecurities Act.
Appears in 1 contract
Shell Company Status. To the Company's knowledge, the The Company is not, and has never been, not currently an issuer identified in Rule 144(i)(1) of under the Securities Act. The Company is, Act and has been for a period of at least 90 days, subject to the reporting requirements of Section 13 or Section 15(d) of the Exchange Act. The Company has filed its current all "Form 10 information" required by Rule 144(i)(1) under the Securities Act with the SEC pursuant to and in accordance with applicable requirements reflecting its status as an entity that is no longer an issuer described in Rule 144(i)(1) and at least one (1) year has elapsed from the date that the Company filed "Form 10 information" with the SECof December 23, 2020.
Appears in 1 contract
Shell Company Status. To the Company's knowledge, the The Company is notnot currently, and since May 6, 2021, has never not been, an issuer identified in Rule 144(i)(1) of under the Securities Act and has filed with the SEC current “Form 10 information” (as defined in Rule 144(i)(3) under the Securities Act. The Company is, and has been for a period of ) at least 90 days, subject 12 calendar months prior to the reporting requirements date of Section 13 or Section 15(d) of the Exchange Act. The Company has filed its current "Form 10 information" with the SEC pursuant to and in accordance with applicable requirements this Agreement reflecting its status as an entity that is no longer an issuer described identified in Rule 144(i)(1) and at least one (1) year has elapsed from under the date that the Company filed "Form 10 information" with the SECSecurities Act.
Appears in 1 contract
Shell Company Status. To the Company's knowledge, the The Company is notnot currently, and since August 19, 2020, has never not been, an issuer identified in Rule 144(i)(1) of under the Securities Act and has filed with the SEC current “Form 10 information” (as defined in Rule 144(i)(3) under the Securities Act. The Company is, and has been for a period of ) at least 90 days, subject 12 calendar months prior to the reporting requirements date of Section 13 or Section 15(d) of the Exchange Act. The Company has filed its current "Form 10 information" with the SEC pursuant to and in accordance with applicable requirements this Agreement reflecting its status as an entity that is no longer an issuer described identified in Rule 144(i)(1) and at least one (1) year has elapsed from under the date that the Company filed "Form 10 information" with the SECSecurities Act.
Appears in 1 contract
Shell Company Status. To the Company's knowledge, the The Company is notnot currently, and since June 13, 2014, has never not been, an issuer identified in Rule 144(i)(1) of under the Securities Act and has filed with the SEC current “Form 10 information” (as defined in Rule 144(i)(3) under the Securities Act. The Company is, and has been for a period of ) at least 90 days, subject 12 calendar months prior to the reporting requirements date of Section 13 or Section 15(d) of the Exchange Act. The Company has filed its current "Form 10 information" with the SEC pursuant to and in accordance with applicable requirements this Agreement reflecting its status as an entity that is no longer an issuer described identified in Rule 144(i)(1) and at least one (1) year has elapsed from under the date that the Company filed "Form 10 information" with the SECSecurities Act.
Appears in 1 contract
Sources: Purchase Agreement (Helius Medical Technologies, Inc.)
Shell Company Status. To the Company's knowledge, the The Company is not, and has never been, an issuer identified in Rule 144(i)(1) of under the Securities Act. The Company is, Act and has been for a period of at least 90 days, subject to filed with the reporting requirements of Section 13 or Section 15(d) of the Exchange Act. The Company has filed its SEC current "Form 10 information" with (as defined in Rule 144(i)(3) under the SEC pursuant Securities Act) at least twelve (12) calendar months prior to and in accordance with applicable requirements the date of this Agreement reflecting its status as an entity that is no longer an issuer described identified in Rule 144(i)(1) and at least one (1) year has elapsed from under the date that the Company filed "Form 10 information" with the SECSecurities Act.
Appears in 1 contract
Shell Company Status. To the Company's knowledge, the The Company is not, and has never been, not currently an issuer identified in Rule 144(i)(1) of under the Securities Act. The Company is, Act and has been for a period of at least 90 days, subject to the reporting requirements of Section 13 or Section 15(d) of the Exchange Act. The Company has filed its current "all “Form 10 information" ” required by Rule 144(i)(1) under the Securities Act with the SEC pursuant to and in accordance with applicable requirements reflecting its status as an entity that is no longer an issuer described in Rule 144(i)(1) and at least one (1) year has elapsed from the date that the Company filed "Form 10 information" with the SECof March 10, 2021.
Appears in 1 contract
Sources: Purchase Agreement (Organicell Regenerative Medicine, Inc.)
Shell Company Status. To the Company's knowledge, the The Company is not, and has never been, was previously an issuer identified in Rule 144(i)(1) of under the Securities Act. The Company isAct and filed with the SEC on February 10, and has been for a period of at least 90 days, subject to the reporting requirements of Section 13 or Section 15(d) of the Exchange Act. The Company has filed its 2022 current "Form 10 information" with (as defined in Rule 144(i)(3) under the SEC pursuant to and in accordance with applicable requirements Securities Act) reflecting its status as an entity that is no longer not an issuer described identified in Rule 144(i)(1144(i)(1)(i) and at least one (1) year has elapsed from under the date that the Company filed "Form 10 information" with the SECSecurities Act.
Appears in 1 contract
Shell Company Status. To the Company's knowledge, the The Company is not, and has never been, not currently an issuer identified in Rule 144(i)(1) of under the Securities Act. The Company is, Act and has been for a period of at least 90 days, subject to the reporting requirements of Section 13 or Section 15(d) of the Exchange Act. The Company has filed its current "all “Form 10 information" ” required by Rule 144(i)(1) under the Securities Act with the SEC pursuant to and in accordance with applicable requirements reflecting its status as an entity that is no longer an issuer described in Rule 144(i)(1) and at least one (1) year has elapsed from the date that the Company filed "Form 10 information" with the SECof September 30, 2021.
Appears in 1 contract
Shell Company Status. To the Company's knowledge, the The Company is not, and has never beennot been at any time in the past 24 months, an issuer identified in Rule 144(i)(1) of the Securities Act. The Company is, and has been for a period of at least 90 days, subject to the reporting requirements of Section 13 or Section 15(d(1) of the Exchange Act. The Company has filed its with the SEC current "“Form 10 information" with ” (as defined in Rule 144(i)(3)) at least 12 calendar months prior to the SEC pursuant to and in accordance with applicable requirements date of this Agreement reflecting its status as an entity that is no longer an issuer described identified in Rule 144(i)(1144(i)(1)and (2) and at least one (1) year has elapsed from the date that the Company timely filed "Form 10 information" with the SECSEC all reports required pursuant to the 1934 Act.
Appears in 1 contract
Sources: Securities Purchase Agreement (Liqtech International Inc)
Shell Company Status. To the Company's knowledge, the The Company is not, and has never beennot been in the past twenty-four (24) months, an issuer identified in Rule 144(i)(1) of under the Securities Act and has filed with the SEC current “Form 10 information” (as defined in Rule 144(i)(3) under the Securities Act. The Company is, and has been for a period of ) at least 90 days, subject twelve (12) months prior to the reporting requirements date of Section 13 or Section 15(d) of the Exchange Act. The Company has filed its current "Form 10 information" with the SEC pursuant to and in accordance with applicable requirements this Agreement reflecting its status as an entity that is no longer an issuer described identified in Rule 144(i)(1) and at least one (1) year has elapsed from under the date that the Company filed "Form 10 information" with the SECSecurities Act.
Appears in 1 contract
Sources: Purchase Agreement (Advaxis, Inc.)
Shell Company Status. To the Company's knowledge, the The Company is not, and has never been, an issuer identified in Rule 144(i)(1) of under the Securities Act. The Company is, Act and has been for a period of at least 90 daysfiled with the SEC on August 25, subject to the reporting requirements of Section 13 or Section 15(d) of the Exchange Act. The Company has filed its 2022 current "Form 10 information" with (as defined in Rule 144(i)(3) under the SEC pursuant to and in accordance with applicable requirements Securities Act) reflecting its status as an entity that is no longer not an issuer described identified in Rule 144(i)(1144(i)(1)(i) and at least one (1) year has elapsed from under the date that the Company filed "Form 10 information" with the SECSecurities Act.
Appears in 1 contract
Sources: Purchase Agreement (PaxMedica, Inc.)
Shell Company Status. To the Company's knowledge, the The Company is not, and has never been, not currently an issuer identified in Rule 144(i)(1) of under the Securities Act. The Company is, Act and has been for a period of at least 90 days, subject to the reporting requirements of Section 13 or Section 15(d) of the Exchange Act. The Company has filed its current "all “Form 10 information" ” required by Rule 144(i)(1) under the Securities Act with the SEC pursuant to and in accordance with applicable requirements reflecting its status as an entity that is no longer an issuer described in Rule 144(i)(1) and at least one (1) year has elapsed from the date that the Company filed "Form 10 information" with the SECof September 30, 2022.
Appears in 1 contract
Shell Company Status. To the Company's knowledge, the The Company is not, and has never been, an issuer identified in Rule 144(i)(1) of under the Securities Act and has filed with the SEC current “Form 10 information” (as defined in Rule 144(i)(3) under the Securities Act. The Company is, and has been for a period of ) at least 90 days, subject twelve (12) calendar months prior to the reporting requirements date of Section 13 or Section 15(d) of the Exchange Act. The Company has filed its current "Form 10 information" with the SEC pursuant to and in accordance with applicable requirements this Agreement reflecting its status as an entity that is no longer not an issuer described identified in Rule 144(i)(1) and at least one (1) year has elapsed from under the date that the Company filed "Form 10 information" with the SECSecurities Act.
Appears in 1 contract
Sources: Purchase Agreement (Veru Inc.)
Shell Company Status. To the Company's knowledge, the The Company is not, and has never been, an issuer identified in Rule 144(i)(1) of under the Securities Act and has filed with the SEC on February 9, 2021 current “Form 10 information” (as defined in Rule 144(i)(3) under the Securities Act. The Company is, and has been for a period of at least 90 days, subject to the reporting requirements of Section 13 or Section 15(d) of the Exchange Act. The Company has filed its current "Form 10 information" with the SEC pursuant to and in accordance with applicable requirements reflecting its status as an entity that is no longer an issuer described identified in Rule 144(i)(1144(i)(1)(i) and at least one (1) year has elapsed from under the date that the Company filed "Form 10 information" with the SECSecurities Act.
Appears in 1 contract
Sources: Purchase Agreement (Advent Technologies Holdings, Inc.)
Shell Company Status. To the Company's knowledge, the The Company is not, and has never beennot been at any time since at least February 3,, 2016, an issuer identified in Rule 144(i)(1) of under the Securities Act and has filed with the SEC current “Form 10 information” (as defined in Rule 144(i)(3) under the Securities Act. The Company is, and has been for a period of ) at least 90 days, subject 12 calendar months prior to the reporting requirements date of Section 13 or Section 15(d) of the Exchange Act. The Company has filed its current "Form 10 information" with the SEC pursuant to and in accordance with applicable requirements this Agreement reflecting its status as an entity that is no longer an issuer described identified in Rule 144(i)(1) and at least one (1) year has elapsed from under the date that the Company filed "Form 10 information" with the SECSecurities Act.
Appears in 1 contract
Sources: Purchase Agreement (Biotricity Inc.)